Oruka Therapeutics, Inc. Common Stock (NASDAQ: ORKA) last traded at $78.19, down 2.69% on the session. The quote above updates while this page is open; the figures below are drawn from Oruka Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Oruka Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ORKA. Its market capitalisation is $5.18 billion.
Valuation measures for Oruka Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.18B |
|---|---|
| Enterprise value | $4.93B |
| Price / book | 4.64 |
| Beta | 1.38 |
Trailing-twelve-month figures tagged in Oruka Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$132.89M |
| Return on equity | -11.92% |
|---|
| Cash | $268.47M |
|---|
Range and volume for ORKA over the past 52 weeks.
| 52-week high | $115.52 |
|---|---|
| 52-week low | $24.88 |
| Volume | 490.8K |
| Average volume | 897.8K |
| Previous close | $80.35 |
Invest a chosen dollar amount in Oruka Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ORKA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.